PO10-TU-40 Mode of action (MoA) of cladribine tablets: activity in lymphocytes and implications for treatment of multiple sclerosis (MS)

  • T. Leist, R. Weissert
  • Journal of the Neurological Sciences, October 2009, Elsevier
  • DOI: 10.1016/s0022-510x(09)70789-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s0022-510x(09)70789-0

The following have contributed to this page: Professor Robert Weissert